Epkinly

Genmab open to more M&A if it makes 'strategic sense,’ CFO says

Anthony Pagano sat down with Fierce at the Jefferies conference to talk M&A, asset ownership and whether the company will become an autoimmune player.

James Waldron Nov 21, 2024 1:05pm